Strategic Analysis of the Kenyan Hypertension MarketsFrost & SullivanApril 8, 2008 134 Pages - SKU: MC1806128 |
|
Pulmonary Arterial Hypertension – Pipeline Review, H1 2012
4/19/2012 | published by: Global Markets Direct
Pulmonary Arterial Hypertension – Pipeline Review, H1 2012 Summary Global Markets Direct’s, 'Pulmonary Arterial Hypertension - Pipeline Review, H1 2012', provides an overview of the Pulmonary Arterial Hypertension therapeutic pipeline. This report provides information on the therapeutic
|
more...
|
$500.00
|
|
Anti-Hypertensives Market to 2017 - Patent Expiries of Blockbusters such as Diovan, Micardis, Avapro and Atacand to Accelerate Erosion
3/23/2012 | published by: GBI Research
Anti-Hypertensives Market to 2017 - Patent Expiries of Blockbusters such as Diovan, Micardis, Avapro and Atacand to Accelerate Erosion Summary GBI Research, the leading business intelligence provider, has released its latest research “Anti-Hypertensives Market to 2017 -
|
more...
|
$3,500.00
|
|
Pulmonary Arterial Hypertension (PAH) Therapeutics - Global Drug Forecasts and Treatment Analysis to 2020
3/31/2012 | published by: GlobalData
Pulmonary Arterial Hypertension (PAH) Therapeutics - Global Drug Forecasts and Treatment Analysis to 2020 Summary GlobalData, Industry analysis specialist, has released its new report, “Pulmonary Arterial Hypertension (PAH) Therapeutics - Global Drug Forecasts and Treatment Analysis to
|
more...
|
$6,995.00
|
|
Portal Hypertension Therapeutics - Pipeline Assessment and Market Forecasts to 2019
2/29/2012 | published by: GlobalData
Portal Hypertension Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Summary GlobalData, the industry analysis specialist, has released its new report, “Portal Hypertension Therapeutics - Pipeline Assessment and Market Forecasts to 2019”. The report is an
|
more...
|
$3,995.00
|
|
Diabetic Hypertension – Pipeline Review, H1 2012
3/19/2012 | published by: Global Markets Direct
Diabetic Hypertension – Pipeline Review, H1 2012 Summary Global Markets Direct’s, 'Diabetic Hypertension - Pipeline Review, H1 2012', provides an overview of the Diabetic Hypertension therapeutic pipeline. This report provides information on the therapeutic development for Diabetic
|
more...
|
$500.00
|
|
Ocular Hypertension – Pipeline Review, H1 2012
3/19/2012 | published by: Global Markets Direct
Ocular Hypertension – Pipeline Review, H1 2012 Summary Global Markets Direct’s, 'Ocular Hypertension - Pipeline Review, H1 2012', provides an overview of the Ocular Hypertension therapeutic pipeline. This report provides information on the therapeutic development for Ocular
|
more...
|
$500.00
|
|
Pulmonary Hypertension Global Clinical Trials Review, H1, 2012
1/27/2012 | published by: GlobalData
Pulmonary Hypertension Global Clinical Trials Review, H1, 2012 Summary GlobalData's clinical trial report, “Pulmonary Hypertension Global Clinical Trials Review, H1, 2012 provides data on the Pulmonary Hypertension clinical trial scenario. This report provides elemental information and data
|
more...
|
$1,000.00
|
|
Hypertension Global Clinical Trials Review, H1, 2012
1/31/2012 | published by: GlobalData
Hypertension Global Clinical Trials Review, H1, 2012 Summary GlobalData's clinical trial report, “Hypertension Global Clinical Trials Review, H1, 2012 provides data on the Hypertension clinical trial scenario. This report provides elemental information and data relating to the
|
more...
|
$1,000.00
|
|
Hypertension – Pipeline Review, H1 2012
2/27/2012 | published by: Global Markets Direct
Hypertension – Pipeline Review, H1 2012 Summary Global Markets Direct’s, 'Hypertension - Pipeline Review, H1 2012', provides an overview of the Hypertension therapeutic pipeline. This report provides information on the therapeutic development for Hypertension, complete with latest
|
more...
|
$500.00
|
|
Pulmonary Arterial Hypertension - Pipeline Review, H2 2011
8/31/2011 | published by: Global Markets Direct
Pulmonary Arterial Hypertension - Pipeline Review, H2 2011 Summary Global Markets Direct’s, 'Pulmonary Arterial Hypertension - Pipeline Review, H2 2011', provides an overview of the Pulmonary Arterial Hypertension therapeutic pipeline. This report provides information on the therapeutic
|
more...
|
$500.00
|
Related Markets
Hypertension Reports
- Pulmonary Arterial Hypertension (PAH) Therapeutics - Global Drug Forecasts and Treatment Analysis to 2020
- Anti-Hypertensives Market to 2017 - Patent Expiries of Blockbusters such as Diovan, Micardis, Avapro and Atacand to Accelerate Erosion
- Portal Hypertension Therapeutics - Pipeline Assessment and Market Forecasts to 2019
- Hypertension Global Clinical Trials Review, H1, 2012
- Pulmonary Hypertension Global Clinical Trials Review, H1, 2012
